A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

RCT (n=228) found no difference in the patient’s clinical status (six-point scale ranging from total recovery to death) at 30 days for convalescent plasma vs placebo (OR 0.83, 95%CI 0.52-1.35). Overall mortality was also not significantly different (10.96% vs 11.43%).

New England Journal of Medicine